ArticleCureus2025
Invasive Lobular Carcinoma of the Breast With Imaging Features Resembling Mucosa-Associated Lymphoid Tissue Lymphoma: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Invasive lobular carcinoma (ILC) is a special histologic type of invasive breast carcinoma characterized by diffuse, single-file infiltration of small discohesive cells. We herein report a case in which differentiation between ILC and primary breast malignant lymphoma was particularly challenging. Imaging findings and core needle biopsy suggested difficulty in distinguishing ILC from mucosa-associated lymphoid tissue (MALT) lymphoma, mainly because the lesion demonstrated dense lymphocytic infiltration. Excisional biopsy ultimately confirmed the diagnosis of ILC. This case highlights the diagnostic challenge posed by ILC presenting with atypical imaging features and marked lymphoid infiltration, which can closely mimic lymphoma. Given the substantial differences in treatment strategies between ILC and primary breast lymphoma, accurate diagnosis necessitates careful integration and summation of imaging, pathological, and immunohistochemical data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.